Top Markets
Coin of the day
Medigen Biotechnology Corp. Medigen Biotechnology Corp.

Medigen Biotechnology Corp.

3176
Classement en actions #19063
Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated... Medigen Biotechnology Corp. is a Taiwanese biopharmaceutical company dedicated to inventing therapies for liver diseases and various forms of cancer. Its product portfolio includes advanced cell therapies like MAGICELL-NK, which leverages natural killer cells, and MAGICELL-GDT, a T-cell-based treatment. A significant pipeline asset for Medigen is OBP-301. This therapeutic has completed Phase I clinical trials for combination therapy in esophageal cancer in Japan. It is currently being evaluated in ongoing Phase I trials in Japan, combining it with immune checkpoint inhibitors (ICIs) for esophageal cancer, and has advanced to Phase II studies in the United States, investigating its use with ICIs for both esophageal and gastric cancer. Established in 1999, Medigen Biotechnology Corp. maintains its corporate headquarters in Taipei, Taiwan.
Prix de l'action
$1.27
Capitalisation boursière
$176.31M
Changement (1 jour)
5.57%
Changement (1 an)
29.36%
Pays
TW
Échange Medigen Biotechnology Corp. (3176)

Catégorie

Le prix 3176 avec la capitalisation boursière de B
Medigen Biotechnology Corp. Medigen Biotechnology Corp.
3176
$1.27
Capitalisation boursière de Medigen Biotechnology Corp.(3176)
Capitalisation boursière: $176.31M
En August 2026, Medigen Biotechnology Corp. a une capitalisation boursière de $176.31M. Cela fait de Medigen Biotechnology Corp. la 19063rd entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Medigen Biotechnology Corp. du 2007 au 2026
3176 par rapport au top 5 des plus populaires stocks
Prix pour 3176 L’actif B La capitalisation boursière de B Résultats
Medigen Biotechnology Corp. Medigen Biotechnology Corp.
$36,986.49 $176.31M
$5.152T +2,922,344.40%
Medigen Biotechnology Corp. Medigen Biotechnology Corp.
$32,568.45 $176.31M
$4.537T +2,573,257.41%
Medigen Biotechnology Corp. Medigen Biotechnology Corp.
$29,923.55 $176.31M
$4.169T +2,364,274.09%
Medigen Biotechnology Corp. Medigen Biotechnology Corp.
$26,146.16 $176.31M
$3.642T +2,065,808.41%
Medigen Biotechnology Corp. Medigen Biotechnology Corp.
$20,133.22 $176.31M
$2.805T +1,590,702.83%